{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2005-N-0464\" sorted by posted_date descending", "rows": [["FDA-2005-N-0464-0249", "FDA", "FDA-2005-N-0464", "Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Corrections", "Rule", "Final Rule", "2021-04-01T04:00:00Z", 2021, 4, "2021-04-01T04:00:00Z", null, "2021-04-01T15:35:43Z", "2021-06677", 0, 0, "0900006484a93032"], ["FDA-2005-N-0464-0244", "FDA", "FDA-2005-N-0464", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approval; Establishment Registration of\nProducers of Drugs and Listing of Drugs in Commercial Distribution and\nBlood Establishment Registration and Product Listing", "Notice", "Announcement", "2017-04-25T04:00:00Z", 2017, 4, "2017-04-25T04:00:00Z", null, "2017-04-25T14:08:22Z", "2017-08305", 0, 0, "090000648257352e"], ["FDA-2005-N-0464-0241", "FDA", "FDA-2005-N-0464", "Tab 3: Draft Final Economic Impact Analysis for a Prospective FDA Rule Governing: Foreign and Domestic Establishment Registration and Listing Requirements for Human Drugs, Certain Biological Drugs, and Animal Drugs -  dated on 08/03/2005", "Supporting & Related Material", "Background Material", "2017-01-09T05:00:00Z", 2017, 1, null, null, "2017-08-15T14:19:34Z", null, 0, 0, "0900006480450bff"], ["FDA-2005-N-0464-0243", "FDA", "FDA-2005-N-0464", "Tab 5: Cost Impacts of the Over-the-Counter Pharmaceutical Labeling Rule - final report dated on 03/05/1999", "Supporting & Related Material", "Background Material", "2017-01-09T05:00:00Z", 2017, 1, null, null, "2017-08-15T14:26:29Z", null, 0, 0, "0900006480450bfe"], ["FDA-2005-N-0464-0242", "FDA", "FDA-2005-N-0464", "Tab 4: Profile of the Prescription drug wholesaling Industry: Examination of Entities Defining Supply and Demand in Drug Distribution - Final Report dated on 02/12/2001", "Supporting & Related Material", "Background Material", "2017-01-09T05:00:00Z", 2017, 1, null, null, "2017-08-15T14:24:05Z", null, 0, 0, "0900006480450bfa"], ["FDA-2005-N-0464-0240", "FDA", "FDA-2005-N-0464", "Tab 2: Letter from FDA/CDER to Eugene S. Peiser & Associates Dated on 08/25/1997", "Supporting & Related Material", "Background Material", "2017-01-09T05:00:00Z", 2017, 1, null, null, "2017-08-15T14:16:37Z", null, 0, 0, "0900006480450bf8"], ["FDA-2005-N-0464-0239", "FDA", "FDA-2005-N-0464", "Tab 1: Letter from National Association of CHAIN DRUG STORES(NACDS) to FDA/CDER on 09/27/2004", "Supporting & Related Material", "Background Material", "2017-01-09T05:00:00Z", 2017, 1, null, null, "2017-08-15T14:13:32Z", null, 0, 0, "0900006480450bfc"], ["FDA-2005-N-0464-0238", "FDA", "FDA-2005-N-0464", "Requirements for Foreign and Domestic Establishment Registration\nand Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Correction", "Rule", "Final Rule", "2016-12-13T05:00:00Z", 2016, 12, "2016-12-13T05:00:00Z", null, "2016-12-13T14:31:48Z", "2016-29774", 0, 0, "09000064823fed93"], ["FDA-2005-N-0464-0235", "FDA", "FDA-2005-N-0464", "Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that Are Regulated Under a Biologics License Application, and Animal Drugs", "Supporting & Related Material", "Background Material", "2016-08-31T04:00:00Z", 2016, 8, null, null, "2016-08-31T14:33:56Z", null, 0, 0, "09000064821b7bb5"], ["FDA-2005-N-0464-0237", "FDA", "FDA-2005-N-0464", "Ref2_ERG Revisions 1995 DRAFT FINAL REPORT ECONOMIC THRESHOLD AND REGULATORY FLEXIBILITY ASSESSMENT OF PROPOSED CHANGES TO THE CURRENT GOOD MANUFACTURING PRACTICE REGULATIONS FOR MANUFACTURING, PROCESSING, PACKING, OR HOLDING DRUGS\n(21CFR210&211) re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under", "Supporting & Related Material", "Background Material", "2016-08-31T04:00:00Z", 2016, 8, null, null, "2016-08-31T14:37:59Z", null, 0, 0, "09000064821b7bb7"], ["FDA-2005-N-0464-0236", "FDA", "FDA-2005-N-0464", "Ref1_BLS_wages_May_2014_NAICS325400 - Pharmaceutical and Medicine Manufacturing re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs", "Supporting & Related Material", "Background Material", "2016-08-31T04:00:00Z", 2016, 8, null, null, "2016-08-31T14:36:09Z", null, 0, 0, "09000064821b7bb6"], ["FDA-2005-N-0464-0234", "FDA", "FDA-2005-N-0464", "Requirements for Foreign and Domestic Establishment Registration\nand Listing for Human Drugs, Including Drugs That Are Regulated\nUnder a Biologics License Application, and Animal Drugs", "Rule", "Final Rule", "2016-08-31T04:00:00Z", 2016, 8, "2016-08-31T04:00:00Z", null, "2016-08-31T14:21:07Z", "2016-20471", 0, 0, "09000064821b68af"], ["FDA-2005-N-0464-0232", "FDA", "FDA-2005-N-0464", "Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-06-01T04:00:00Z", 2009, 6, "2009-06-01T04:00:00Z", "2009-06-02T03:59:59Z", "2010-08-13T15:19:06Z", "E9-12743", 0, 0, "09000064809c1db8"], ["FDA-2005-N-0464-0231", "FDA", "FDA-2005-N-0464", "Guideline re Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability", "Other", "Guidance", "2009-06-01T04:00:00Z", 2009, 6, "2009-06-01T04:00:00Z", null, "2016-12-08T18:55:55Z", null, 0, 0, "09000064809c15da"], ["FDA-2005-N-0464-0230", "FDA", "FDA-2005-N-0464", "Notice of Availability of Data re Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability", "Notice", "Notice of Availability", "2009-06-01T04:00:00Z", 2009, 6, "2009-06-01T04:00:00Z", "2009-06-02T03:59:59Z", "2020-10-10T01:01:27Z", "E9-12743", 0, 0, "09000064809c0c71"], ["FDA-2005-N-0464-0233", "FDA", "FDA-2005-N-0464", "Providing Regulatory Submissions in Electronic Format \u2013 Drug Establishment Registration and Drug Listing", "Other", "Guidance", "2009-05-28T04:00:00Z", 2009, 5, "2009-05-28T04:00:00Z", null, "2020-10-10T01:01:01Z", null, 0, 0, "09000064809c1ad2"], ["FDA-2005-N-0464-0229", "FDA", "FDA-2005-N-0464", "Compressed Gas Association - Supplement Comment [re FDA-2005-N-0464-0080.1]", "Other", "SUP-Supplement", "2009-04-16T04:00:00Z", 2009, 4, "2009-04-16T04:00:00Z", null, "2014-12-16T22:17:42Z", null, 0, 0, "090000648095560b"], ["FDA-2005-N-0464-0222", "FDA", "FDA-2005-N-0464", "Hospira Inc. - \"The Proposed Changes to NDC System Legacy NDC Numbers and Compliance \" (Thomas F. Willer) - Testimony", "Other", "TS-Testimony", "2009-04-15T04:00:00Z", 2009, 4, "2009-04-15T04:00:00Z", null, "2017-01-18T17:36:54Z", null, 0, 0, "0900006480450c46"], ["FDA-2005-N-0464-0223", "FDA", "FDA-2005-N-0464", "Perrigo - \"Experience with NDC Numbers\" - Testimony", "Other", "TS-Testimony", "2009-04-15T04:00:00Z", 2009, 4, "2009-04-15T04:00:00Z", null, "2017-01-18T17:38:31Z", null, 0, 0, "0900006480450c48"], ["FDA-2005-N-0464-0224", "FDA", "FDA-2005-N-0464", "Consumer Healthcare Products Association (CHPA) - \"\"FDA Public Meeting \u2013 Proposed Changes to the National Drug Code (NDC) Number System\" (Paul J. Larsen) - Testimony", "Other", "TS-Testimony", "2009-04-15T04:00:00Z", 2009, 4, "2009-04-15T04:00:00Z", null, "2017-01-18T17:40:20Z", null, 0, 0, "0900006480450c4a"], ["FDA-2005-N-0464-0226", "FDA", "FDA-2005-N-0464", "Guidance for Industry Providing Regulatory Submissions in Electronic\nFormat -Drug Establishment Registration and Drug Listing", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-04-15T04:00:00Z", 2009, 4, "2009-04-15T04:00:00Z", null, "2019-10-17T19:56:23Z", null, 0, 0, "0900006480667d76"], ["FDA-2005-N-0464-0225", "FDA", "FDA-2005-N-0464", "AABB - \"National Drug Codes for HCT/Ps\" (M. Allene Carr-Greer) - Testimony", "Other", "TS-Testimony", "2009-04-15T04:00:00Z", 2009, 4, "2009-04-15T04:00:00Z", null, "2017-01-18T17:41:41Z", null, 0, 0, "0900006480450c4f"], ["FDA-2005-N-0464-0220", "FDA", "FDA-2005-N-0464", "Notice re Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Drug Establishment Registration and Drug Listing", "Notice", "General Notice", "2008-10-23T04:00:00Z", 2008, 10, null, null, "2016-12-08T19:05:18Z", "E8-25338", 0, 0, "090000648077419a"], ["FDA-2005-N-0464-0150", "FDA", "FDA-2005-N-0464", "Shipping Label re Comment from Bristol-Myers Squibb Company", "Supporting & Related Material", "Transmittals", "2008-09-12T04:00:00Z", 2008, 9, null, null, "2016-11-17T18:18:40Z", null, 0, 0, "0900006480450d18"], ["FDA-2005-N-0464-0073", "FDA", "FDA-2005-N-0464", "Background Material re The Compressed Gas Assaciation (CCA) and the Gases and Welding Distributors Association (GAWDA)", "Supporting & Related Material", "Background Material", "2008-09-10T04:00:00Z", 2008, 9, null, null, "2017-08-14T19:23:12Z", null, 0, 0, "0900006480450c6f"], ["FDA-2005-N-0464-0030", "FDA", "FDA-2005-N-0464", "Request Extension of Comment Period from Compressed Gas Association", "Other", "EXT-Request for Extension Comment Due Date", "2008-09-09T04:00:00Z", 2008, 9, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-07-21T16:15:19Z", null, 0, 0, "0900006480450c0c"], ["FDA-2005-N-0464-0034", "FDA", "FDA-2005-N-0464", "Request for Extension re Comment from L. Perrigo Company", "Other", "Request for Extension", "2008-09-09T04:00:00Z", 2008, 9, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2016-12-13T20:38:04Z", null, 0, 0, "0900006480450c13"], ["FDA-2005-N-0464-0033", "FDA", "FDA-2005-N-0464", "Request for Extension re Comment from Consumer Healthcare Products Association (CHPA)", "Other", "Request for Extension", "2008-09-09T04:00:00Z", 2008, 9, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-14T20:26:17Z", null, 0, 0, "0900006480450c12"], ["FDA-2005-N-0464-0022", "FDA", "FDA-2005-N-0464", "Notice of Data Availability re Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Drug Establishment Registration and Drug Listing; Availability", "Notice", "Notice of Data Availability", "2008-07-11T04:00:00Z", 2008, 7, "2008-07-11T04:00:00Z", "2008-09-10T03:59:59Z", "2024-11-12T04:16:53Z", "E8-15801", 1, 0, "090000648066791e"], ["FDA-2005-N-0464-0021", "FDA", "FDA-2005-N-0464", "Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; ReOpening of Comment Period", "Proposed Rule", "Extension of Comment Period", "2007-02-08T05:00:00Z", 2007, 2, "2007-02-07T05:00:00Z", "2007-02-27T04:59:59Z", "2016-11-10T15:32:42Z", null, 0, 0, "0900006480450d0d"], ["FDA-2005-N-0464-0020", "FDA", "FDA-2005-N-0464", "Letter from FDA/CDER Response to National Committee on Vital", "Other", "Letter(s)", "2007-01-29T05:00:00Z", 2007, 1, null, null, "2016-12-13T21:15:43Z", null, 0, 0, "0900006480450ca3"], ["FDA-2005-N-0464-0015", "FDA", "FDA-2005-N-0464", "See FDA-2005-N-0464-0014", "Supporting & Related Material", "TR-Transcript", "2007-01-12T05:00:00Z", 2007, 1, null, null, "2009-04-15T23:58:47Z", null, 0, 0, "0900006480450c43"], ["FDA-2005-N-0464-0014", "FDA", "FDA-2005-N-0464", "Transcript of Public Meeting:  Proposed Changes to the National Drug Code (NDC) System, December 11, 2006", "Other", "TR-Transcript", "2007-01-12T05:00:00Z", 2007, 1, null, null, "2017-07-24T15:11:28Z", null, 0, 0, "0900006480450c42"], ["FDA-2005-N-0464-0016", "FDA", "FDA-2005-N-0464", "FDA/CDER - \"Proposed Revised 21 CFR 207 Electronic Drug Registration and Listing Systems (e-DRLS)\" - Testimony", "Other", "TS-Testimony", "2007-01-12T05:00:00Z", 2007, 1, null, null, "2017-01-18T17:37:35Z", null, 0, 0, "0900006480450c44"], ["FDA-2005-N-0464-0017", "FDA", "FDA-2005-N-0464", "Testimony re FDA-2005-N-0464-0016", "Supporting & Related Material", "Testimony", "2007-01-12T05:00:00Z", 2007, 1, null, null, "2016-12-13T20:44:03Z", null, 0, 0, "0900006480450c45"], ["FDA-2005-N-0464-0008", "FDA", "FDA-2005-N-0464", "Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Public Meeting; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2006-10-31T05:00:00Z", 2006, 10, "2006-10-30T05:00:00Z", "2007-01-27T04:59:59Z", "2016-12-19T17:17:44Z", null, 0, 0, "0900006480450c15"], ["FDA-2005-N-0464-0006", "FDA", "FDA-2005-N-0464", "REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2006-09-08T04:00:00Z", 2006, 9, null, null, "2017-07-24T14:15:25Z", null, 0, 0, "0900006480450c08"], ["FDA-2005-N-0464-0005", "FDA", "FDA-2005-N-0464", "REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2006-09-08T04:00:00Z", 2006, 9, null, null, "2017-07-24T14:17:07Z", null, 0, 0, "0900006480450c07"], ["FDA-2005-N-0464-0007", "FDA", "FDA-2005-N-0464", "REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2006-09-08T04:00:00Z", 2006, 9, null, null, "2017-07-24T14:12:42Z", null, 0, 0, "0900006480450c09"], ["FDA-2005-N-0464-0002", "FDA", "FDA-2005-N-0464", "Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 201-300)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-15T14:33:55Z", null, 0, 0, "0900006480450bee"], ["FDA-2005-N-0464-0001", "FDA", "FDA-2005-N-0464", "Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 301-319)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-15T14:32:51Z", null, 0, 0, "0900006480450bce"], ["FDA-2005-N-0464-0003", "FDA", "FDA-2005-N-0464", "Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 1-100)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-15T14:35:39Z", null, 0, 0, "0900006480450bf2"], ["FDA-2005-N-0464-0004", "FDA", "FDA-2005-N-0464", "Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 101-200)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2016-03-14T19:19:42Z", null, 0, 0, "0900006480450bf3"]], "truncated": false, "filtered_table_rows_count": 43, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2005-N-0464"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464", "results": [{"value": "FDA", "label": "FDA", "count": 43, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2005-N-0464", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&document_type=Proposed+Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&document_type=Notice", "selected": false}, {"value": "Rule", "label": "Rule", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464", "results": [{"value": 2009, "label": 2009, "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2009", "selected": false}, {"value": 2006, "label": 2006, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2006", "selected": false}, {"value": 2008, "label": 2008, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2008", "selected": false}, {"value": 2007, "label": 2007, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2007", "selected": false}, {"value": 2017, "label": 2017, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2017", "selected": false}, {"value": 2016, "label": 2016, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2016", "selected": false}, {"value": 2021, "label": 2021, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&posted_year=2021", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=comment_end_date"}, {"name": "fr_doc_num", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=fr_doc_num"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2005-N-0464&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 276.00325900129974, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}